|
Harnessing genetically engineered hematopoietic progenitor cells to redirect the tumor immune microenvironment against glioblastoma (TEM-GBM Study). |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
Quintino Giorgio D'Alessandris |
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - Elekta (Inst) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Genenta Science |
Stock and Other Ownership Interests - Genenta Science (Inst) |
| |
|
Stock and Other Ownership Interests - Genenta Science |
Honoraria - Genenta Science |
Consulting or Advisory Role - Genenta Science |
Research Funding - Genenta Science |
Patents, Royalties, Other Intellectual Property - San Raffaele Institute (Inst) |
| |
|
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA Publication number: 20170321281 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours Patent number: 8129183 METHOD FOR S |
| |
|
No Relationships to Disclose |